Kirk K Lin

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Durability of infliximab dose intensification in Crohn's disease
    Kirk K Lin
    Division of Gastroenterology, Department of Internal Medicine, University of California at San Francisco, San Francisco, CA, USA
    Dig Dis Sci 57:1013-9. 2012

Detail Information

Publications1

  1. ncbi Durability of infliximab dose intensification in Crohn's disease
    Kirk K Lin
    Division of Gastroenterology, Department of Internal Medicine, University of California at San Francisco, San Francisco, CA, USA
    Dig Dis Sci 57:1013-9. 2012
    ..Dose intensification is a common approach to treat Crohn's disease (CD) patients who lose response to infliximab maintenance therapy. Few studies have reported upon its long-term efficacy or predictors of response...